In-vitro Release and Stability Studies of Raloxifene Loaded Solid-Lipid Nanoparticle
Navin Chandra Pant & Vijay Juyal · Journal of Pharmaceutical Research International · 2021
Objective: Raloxifene HCl (RLX) show a low oral bioavailability (<2%) in human due to its poor solubility and extensive (>90%) first-pass metabolism. To overcome these limitations, the present investigation deals with the development of Compritol 888 ATO based optimized RLX...
Open access
Research Article
10.9734/jpri/2021/v33i39B32201